Allergan Asks Fed. Circ. To Revive Pinkeye Patent Suit
Allergan Inc. and two Japanese pharmaceutical companies urged the Federal Circuit on Thursday to revive its second infringement suit against Apotex Inc. over a patent for the pinkeye treatment Zymar, saying...To view the full article, register now.
Already a subscriber? Click here to view full article